Nakayama M - Search Results

1

Suppression of N(epsilon)-(carboxymethyl)lysine generation by the antioxidant N-acetylcysteine.

Nakayama M, Izumi G, Nemoto Y, Shibata K, Hasegawa T, Numata M, Wang K, Kawaguchi Y, Hosoya T. Nakayama M, et al. Perit Dial Int. 1999 May-Jun;19(3):207-10. Perit Dial Int. 1999. PMID: 10433156

2

Tranexamic acid increases peritoneal ultrafiltration volume in patients on CAPD.

Kuriyama S, Nakayama M, Tomonari H, Kawaguchi Y, Hosoya T. Kuriyama S, et al. Among authors: nakayama m. Perit Dial Int. 1999 Jan-Feb;19(1):38-44. Perit Dial Int. 1999. PMID: 10201339

3

Sodium sulfite and N-acetylcysteine: new additives to dialysate for inhibiting formation of glucose degradation products and advanced glycation end-products.

Sakai A, Nakayama M, Numata M, Takesawa S, Nakamoto M. Sakai A, et al. Among authors: nakayama m. Adv Perit Dial. 2001;17:66-70. Adv Perit Dial. 2001. PMID: 11510300

4

The effect of ultra-low sodium dialysate in CAPD. A kinetic and clinical analysis.

Nakayama M, Yokoyama K, Kubo H, Matsumoto H, Hasegawa T, Shigematsu T, Kawaguchi Y, Sakai O. Nakayama M, et al. Clin Nephrol. 1996 Mar;45(3):188-93. Clin Nephrol. 1996. PMID: 8706361

5

Is atherosclerosis accelerated by CAPD?

Kawaguchi Y, Kubo H, Yamamoto H, Nakayama M, Yokoyama K, Shigematsu T, Sakai O. Kawaguchi Y, et al. Among authors: nakayama m. Perit Dial Int. 1996;16 Suppl 1:S223-30. Perit Dial Int. 1996. PMID: 8728197

6

Low calcium (1.25 mmol/L) dialysate can normalize relative hypoparathyroidism in CAPD patients with low bone turnover.

Shigematsu T, Kawaguchi Y, Kubo H, Nakayama M, Kato N, Yamamoto H, Osaka N, Hayakawa H, Ogawa A, Sakai O. Shigematsu T, et al. Among authors: nakayama m. Adv Perit Dial. 1996;12:250-6. Adv Perit Dial. 1996. PMID: 8865914

7

Current issues of continuous ambulatory peritoneal dialysis.

Kawaguchi Y, Hasegawa T, Kubo H, Yamamoto H, Nakayama M, Shigematsu T. Kawaguchi Y, et al. Among authors: nakayama m. Artif Organs. 1995 Dec;19(12):1204-9. doi: 10.1111/j.1525-1594.1995.tb02286.x. Artif Organs. 1995. PMID: 8967875 Review.

8

Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD.

Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takazoe K, Katoh N, Hayakawa H, Osaka N, Yamamoto H, Ogawa A, Kubo H, Shigematsu T, Sakai O, Horiuchi S. Nakayama M, et al. Kidney Int. 1997 Jan;51(1):182-6. doi: 10.1038/ki.1997.22. Kidney Int. 1997. PMID: 8995732 Free article.

9

Issues affecting the longevity of the continuous peritoneal dialysis therapy.

Kawaguchi Y, Hasegawa T, Nakayama M, Kubo H, Shigematu T. Kawaguchi Y, et al. Among authors: nakayama m. Kidney Int Suppl. 1997 Nov;62:S105-7. Kidney Int Suppl. 1997. PMID: 9350695

10

Successful treatment of tumoral calcinosis using CAPD combined with hemodialysis with low-calcium dialysate.

Kuriyama S, Tomonari H, Nakayama M, Kawaguchi Y, Sakai O. Kuriyama S, et al. Among authors: nakayama m. Blood Purif. 1998;16(1):43-8. doi: 10.1159/000014312. Blood Purif. 1998. PMID: 9513762

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,330 results

Search Page

Filters